Q2 2026 saw a 13% sales decline due to currency headwinds and geopolitical disruptions, but gross margin improved by 2.2 points. OEM segment showed organic growth and profitability, while diagnostics faced a sharp drop. Liquidity remains tight amid ongoing cost controls.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.